PAVM - Lucid Diagnostics launches test centers in 3 states

Lucid Diagnostics (NASDAQ:LUCD), a majority-owned subsidiary of PAVmed (NASDAQ:PAVM), launched Lucid Test Centers in three new metropolitan areas—Seattle, Washington; Portland, Oregon; and Boise, Idaho. The companies said that in these cities patients with chronic heartburn, also known as gastroesophageal reflux disease (GERD), can now undergo a brief, non-invasive, office-based test to detect esophageal precancer. The company noted that the new centers operate in leased medical office suites.

For further details see:

Lucid Diagnostics launches test centers in 3 states